Tadashi Ohara

Suggest Changes

Writes About:

Learn More
BACKGROUND/AIMS Therapeutic results for patients with hepatitis C and B complex or patients with genotype lb high viral load treatment-resistant hepatitis C are still not sufficient. The therapeutic(More)
The genomic DNA of toll-like receptor (TLR) 2, TLR4, radioprotective 105, TLR6, and TLR9 were examined for mutations in 48 patients with gastric cancer. Of these, 22 had well-differentiated and 20(More)